Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 30, 2008 03:07 ET | Source: Epigenomics AG

First Subjects Enrolled in Epigenomics Sponsored PRESEPT Colorectal Cancer Screening Study

SEATTLE and BERLIN, June 30, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer detection...
June 18, 2008 03:12 ET | Source: Epigenomics AG

Epigenomics Successfully Completes Larger Clinical Study in Early Lung Cancer Detection

BERLIN and SEATTLE, June 18, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer detection...
June 09, 2008 02:38 ET | Source: Epigenomics AG

Epigenomics Successfully Completes Clinical Study in Lung Cancer Diagnosis

BERLIN and SEATTLE, June 9, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer based on...
May 06, 2008 02:55 ET | Source: Epigenomics AG

Epigenomics AG Reports First Quarter 2008 Financial Results

Key Figures -- Revenue: EUR 0.9 million in Q1 2008, up by 12% (Q1 2007: EUR 0.8 million) -- EBIT: EUR -3.0 million in Q1 2008, improved by 13% (Q1 2007: EUR -3.4 million) -- Net loss:...
April 21, 2008 02:17 ET | Source: Epigenomics AG

Epigenomics AG Successfully Validates Optimized Blood-Based Colorectal Cancer Assay in Two Independent Clinical Studies

BERLIN and SEATTLE, April 21, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer based on...
April 14, 2008 02:41 ET | Source: Epigenomics AG

Epigenomics AG Presents Data on Novel Prostate Cancer Biomarkers at AACR

BERLIN and SEATTLE, April 14, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt Prime Standard: ECX), a molecular diagnostics company focusing on the development and commercialization of in-vitro...
April 01, 2008 03:15 ET | Source: Epigenomics AG

Epigenomics and TIB MOLBIOL Launch First in a Series of Products At Analytica 2008

BERLIN and SEATTLE, April 1, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECS) (Prime Standard), a molecular diagnostics company developing products based on DNA methylation analysis, together...
March 31, 2008 02:18 ET | Source: Epigenomics AG

Epigenomics AG Reports Financial Results for a Successful Fiscal Year 2007

Successful execution on corporate strategy - Financial and strategic framework set for the future Financials in line with latest expectations: -- Full year revenue EUR 2.6 million --...
March 13, 2008 10:54 ET | Source: Epigenomics AG

Announcement acc. to Sections 37v-x WpHG: Epigenomics AG: Announcement According to Sections 37v, 37w, 37x, 37y WpHG With the Aim of European-Wide Distribution

BERLIN, March 13, 2008 (PRIME NEWSWIRE) -- Advance announcement on the disclosure of financial statements by Epigenomics AG. Epigenomics AG hereby announces that in the fiscal year 2008 the...
March 13, 2008 07:23 ET | Source: Epigenomics AG

Epigenomics AG to Host Press Conference and Analyst Meeting for 2007 Annual Results

BERLIN, Germany and SEATTLE, March 13, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a cancer molecular diagnostics company, will hold its annual press conference and analyst meeting on...